Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.

Saved in:
Bibliographic Details
Title: Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Authors: Pagano G; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery; and Translational Area, Roche Innovation Center Basel, Basel, Switzerland. gennaro.pagano@roche.com.; University of Exeter Medical School, London, UK. gennaro.pagano@roche.com., Trundell D; Roche Products Ltd, Welwyn Garden City, UK., Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Pavese N; Clinical Ageing Research Unit, Newcastle University, Newcastle upon Tyne, UK., Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, USA., Postuma RB; Department of Neurology, McGill University, and Montreal Neurological Institute, Montreal, Canada., Shariati N; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Monnet A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Moore E; Roche Products Ltd, Welwyn Garden City, UK., Davies EW; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Svoboda H; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery; and Translational Area, Roche Innovation Center Basel, Basel, Switzerland.; Roche Diagnostics GmbH, Penzberg, Germany., Pross N; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bonni A; Roche Pharma Research and Early Development (pRED), Neuroscience and Rare Diseases Discovery; and Translational Area, Roche Innovation Center Basel, Basel, Switzerland., Nikolcheva T; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Corporate Authors: PASADENA Investigators, Prasinezumab Study Group
Source: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2025 Aug 13; Vol. 11 (1), pp. 241. Date of Electronic Publication: 2025 Aug 13.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2373-8057
DOI:10.1038/s41531-025-01103-y